|
Real-time Estimate
Cboe BZX
07:06:30 30/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 6.145 USD | -1.84% |
|
-6.71% | -39.11% |
| Market Cap | 23Cr 20Cr 19Cr 17Cr 32Cr 2.17TCr 32Cr 226.09Cr 87Cr 1.11TCr 85Cr 83Cr 3.56TCr | P/E 2026 * |
-1.56x | P/E 2027 * | -1.73x |
|---|---|---|---|---|---|
| Enterprise Value | 20Cr 17Cr 16Cr 15Cr 28Cr 1.88TCr 28Cr 195.92Cr 76Cr 958.4Cr 73Cr 72Cr 3.08TCr | EV / Sales 2026 * |
16.1x | EV / Sales 2027 * | -2.33x |
| Free-Float |
85.81% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| TRDA | Delayed | |
CBOE
| TRDA | Real-time |
Last Transcript: Entrada Therapeutics, Inc.
| 21/22/21 | Nipte winst op Wall Street | |
| 21/22/21 | Wall Street licht hoger | |
| 20/22/20 | Wall Street richting rode opening |
| 1 day | -1.84% | ||
| 1 week | -6.71% | ||
| Current month | -11.21% | ||
| 1 month | -10.57% | ||
| 3 months | -18.81% | ||
| 6 months | -47.53% | ||
| Current year | -39.11% |
| 1 week | 5.92 |  | 6.47 |
| 1 month | 5.92 | | 7.7 |
| Current year | 5.63 | | 16.45 |
| 1 year | 5.55 | | 16.45 |
| 3 years | 4.93 | | 21.79 |
| 5 years | 4.93 | | 36.85 |
| 10 years | 4.93 | | 36.85 |
| Manager | Title | Age | Since |
|---|---|---|---|
Dipal Doshi
CEO | Chief Executive Officer | 50 | 01/08/2017 |
Kory Wentworth
DFI | Director of Finance/CFO | 47 | 01/11/2020 |
Nathan Dowden
PSD | President | 56 | 01/01/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Dipal Doshi
BRD | Director/Board Member | 50 | 01/08/2017 |
Kush Parmar
CHM | Chairman | 45 | 01/12/2020 |
Peter Kim
BRD | Director/Board Member | 67 | 01/12/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 09/09/26 | MPM BioImpact LLC
| Sell | Company | -28,837 | 0.0741% | |
| 09/09/26 | MPM BioImpact LLC
| Sell | Company | -28,837 | 0.0741% | |
| 03/09/26 | MPM BioImpact LLC
| Sell | Company | -32,263 | 0.0829% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.84% | -6.71% | +7.19% | -60.38% | 23Cr | |
| -0.70% | -4.28% | +52.62% | +86.42% | 7.15TCr | |
| -0.59% | +0.96% | +36.71% | +80.69% | 6.01TCr | |
| -1.06% | +3.10% | +9.86% | +37.74% | 4.89TCr | |
| +0.31% | -0.41% | +48.84% | +36.72% | 4.43TCr | |
| -0.06% | +6.03% | +343.85% | +638.73% | 4.38TCr | |
| +2.92% | -0.76% | +9.75% | +103.07% | 4.15TCr | |
| +0.34% | +0.22% | +5.18% | +47.36% | 3.01TCr | |
| +4.77% | +6.16% | +36.77% | +26.10% | 2.8TCr | |
| -0.73% | -4.30% | -18.37% | +357.94% | 2.53TCr | |
| Average | +0.34% | -0.72% | +53.24% | +135.44% | 3.94TCr | |
| Weighted average by Cap. | +0.31% | -0.16% | +63.02% | +147.21% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.22Cr 1.07Cr 1.02Cr 92.12L 1.73Cr 116.74Cr 1.74Cr 12Cr 4.7Cr 60Cr 4.57Cr 4.47Cr 191.83Cr | 2.29Cr 2.02Cr 1.91Cr 1.73Cr 3.25Cr 219.36Cr 3.28Cr 23Cr 8.83Cr 112.01Cr 8.58Cr 8.4Cr 360.46Cr |
| Net income | -17Cr -15Cr -15Cr -13Cr -25Cr -1.67TCr -25Cr -174.65Cr -67Cr -854.34Cr -65Cr -64Cr -2.75TCr | -18Cr -16Cr -15Cr -14Cr -26Cr -1.77TCr -26Cr -184.74Cr -71Cr -903.7Cr -69Cr -68Cr -2.91TCr |
| Net Debt | -3.01Cr -2.66Cr -2.52Cr -2.28Cr -4.28Cr -289.05Cr -4.32Cr -30Cr -12Cr -147.6Cr -11Cr -11Cr -474.99Cr | -28Cr -25Cr -23Cr -21Cr -40Cr -2.68TCr -40Cr -279.55Cr -107.74Cr -1.37TCr -104.79Cr -102.51Cr -4.4TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/26/30 | $6.260 | +0.64% | 2,68,586 |
| 28/26/28 | $6.220 | +0.97% | 4,42,585 |
| 25/26/25 | $6.160 | -0.96% | 3,74,038 |
| 24/26/24 | $6.220 | -4.31% | 3,19,117 |
| 23/26/23 | $6.500 | -3.13% | 2,82,769 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TRDA Stock
Select your edition
All financial news and data tailored to specific country editions
